Five people are standing next to each other for a team photo underneath a large...
The research team at UPV

Image source: UPV 

News • Medical materials

Self-disinfecting fabric uses light to kill bacteria, fungi, viruses

A team from the Alcoy campus of the Universitat Politècnica de València (UPV), the Research Institute for Chemical Technology (ITQ, CSIC-UPV), the Research Institute for Mediterranean Agroforestry (IAM UPV) and the Joint Research Unit between the UPV and the Health Research Institute at La Fe Hospital in Valencia (UPV-IISLaFe) has developed a new self-disinfecting cotton fabric capable of eliminating bacteria, fungi and viruses in hospital settings using visible light.

The researchers present their findings in the journal ACS Applied Materials & Interfaces. 

"The material incorporates two photoactive compounds which, when exposed to light, generate a highly reactive form of oxygen that damages the microorganisms adhering to the fabric, thereby eliminating them," explains Alberto Blázquez-Moraleja (ITQ CSIC-UPV). 

"We aim to develop fabrics capable of reducing the presence of microorganisms such as bacteria, fungi and viruses in hospitals and other healthcare settings, thereby mitigating some of the problems associated with conventional antimicrobials, such as a loss of efficacy with use or when washed, or the promotion of resistant microorganisms. And that is precisely what we have achieved in this study," says Marilés Bonet of the Textile and Paper Engineering Department at the UPV's Alcoy campus. 

Even after 20 [washing] cycles, it maintained a bactericidal efficacy above the reference levels used for antimicrobial fabrics

Pilar Moya

In laboratory tests, the fabric completely inactivated Escherichia coli within 60 minutes and Enterococcus faecalis within 20 minutes when exposed to light. It also achieved a reduction in Candida albicans within three hours. "The material also retains a significant proportion of its activity after repeated washes. Even after 20 cycles, it maintained a bactericidal efficacy above the reference levels used for antimicrobial fabrics," says Pilar Moya, from the UPV's Research Institute for Mediterranean Agroforestry. 

The hospital validation was carried out in the rooms of 12 patients at La Fe University and Polytechnic Hospital in Valencia. The fabrics were placed in two areas of the rooms for 48 hours: the bed rails, exposed to light, and the mattresses, which received less light. In addition, the research team used untreated cotton fabrics as a control. 

"In the hospital rooms, the fabric exposed to light accumulated 75% fewer microorganisms than a conventional cotton fabric placed under the same conditions. When the material was placed in an area without direct light, the reduction was much lower, just 25%, confirming that its antimicrobial effect depends largely on lighting. The efficacy was particularly high against Gram-positive bacteria, with their presence reduced by 77.5%," notes Inmaculada Andreu from the UPV-IIS La Fe Joint Research Unit. 

As the team of researchers highlights, the process used to manufacture this fabric could be easily integrated into standard textile-finishing techniques, facilitating the large-scale development of new self-disinfecting textiles for hospitals. 


Source: Universitat Politècnica de València 

12.10.2026

Related articles

Photo

News • Surface treatment

Preventing deadly hospital infections without antibiotics

Hospital-acquired infections are dangerous for patients and costly for clinics. A novel surface treatment could help improve the safety of medical devices and ease the economic burden.

Photo

Article •

Killing copper

In Europe, nosocomial infections cause about 25,000 deaths every year. Copper has strong antibiotic effects and may reduce hospital acquired infections.

Photo

News • Infection prevention

Needle-free ‘universal vaccine’ could protect from future virus outbreaks

A research team has developed a way to engineer better vaccines that could provide broad protection from thousands of variants of viruses - such as coronaviruses or Ebola - in a single vaccine.

Subscribe to Newsletter